Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc > Nothing like some 'leaks' on the FDA Resubmission

<< Previous

Bullboard Posts

Next >>

Comment by Trogarzonon Apr 28, 2023 10:54am

37 Views

Post# 35419152

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Nothing like some 'leaks' on the FDA Resubmission

It might just be the last you get to make a difference with your vote before they get the all clear to delute us into oblivion to finance a pipedream they can't any value from the market or partners. I wouyld allign myself with other big shareholders to get people on the board that can actually bring changes to the way they run things overthere.

<< Previous

Bullboard Posts

Next >>

Rich TV Live's Stocks to Watch this week (June 28, 2024)